DEVICE FOR CONTACTING BLOOD FLOWS

Abstract: A device for conditioning a blood flow such as, for example, a pumping device (artificial ventricle) or a heart valve prosthesis, including at least one element (4) with portions which are exposed to the blood and which are deformable cyclically at a frequency comparable to the frequency of the heartbeat, has a coating (13) of biocompatible carbonaceous material on at least part of the portions exposed to the blood.

Description: The present invention relates to a device in use contacting a blood flow according to the first part of claim 1. Such a device is disclosed in DE-A-3 116 040. Devices of this type may include, for example, a blood chamber with at least one deformable wall portion, the deformation being usable to pump the blood. This is the case, for example, in so-called blood pumps for ventricular-assistance systems which are fitted to patients affected by very serious cardiac insufficiency whilst awaiting the recovery of the functioning of the natural or implanted biological heart, or whilst awaiting a transplant, or, indeed, in pumps used for establishing circulation outside the body during open-heart surgery. Structurally-similar devices are constituted by so-called artificial ventricles or artificial hearts which can be implanted in the body of a patient to replace or assist a diseased heart muscle. The most recent results of research in the field of devices for assisting or replacing parts or functions of the cardiovascular system have demonstrated the advantages and limitations of the use of polymeric-materials used up till now in the production of these devices. This relates, in particular, to polymeric-parts made from sheets, films or tubes of polymeric substances with continuous or microporous structures, and smooth or rough surfaces. The use of this type of material has also been considered for the production of cyclically-deformable parts exposed to the blood in other blood-flow contacting devices, for example for the production of the valve leaflets of heart-valve prostheses (or, in short, valves). In the latter case, one is concerned with an extension of the use of polymeric materials: according to solutions which can now be considered conventional, materials of this type are used in the production of the stent of the valve or (in the form of threads variously woven or interlaced) in the production of the suture ring thereof. The use of polymeric materials for the production of valve leaflets opens up a completely new field of use since it involves the use of the polymeric material not only for producing elements (such as the stent or the suture ring) which must have a certain degree of flexibility in order to adapt to the implant situation, but also for producing elements (such as the leaflets) which are to be deformed cyclically at a frequency substantially equal to the frequency of the heartbeat. This aspect thus has a substantial affinity with the problems found in use of the blood-pumping devices described above. The polymers most commonly used in the cardiovascular field are polyurethanes and polytetrafluorethylene (PTFE) with a lesser use of other synthetic polymers such as polyesters or silicone polymers. A characteristic common to the materials concerned is that of being produced in a macroscopically continuous form, whilst the microstructure of the materials in question may be solid or microporous, this being affected by the synthesising of production technique. The main advantages of these materials in use in the cardiovascular field are their good mechanical properties, resilience and flexibility associated with their ability to contain the blood without allowing it to seep through the material appreciably. Even in the case of microporous materials, in fact, the dimensions of the pores are such as to allow a moderate penetration of biological cells, but not significant blood flow. Other advantageous characteristics of these materials are in their good chemical inertness and stability, even in a biological environment. These characteristics, are not, however, accompanied by a wholly satisfactory degree of biocompatibility and haemocompatibility. This incomplete compatibility gives rise to some phenomena which limit significantly the possibilities of use of these materials in the production of blood-flow contacting devices. A first harmful effect is the formation of thrombi and/or clotting on contact with the blood. These thrombi may become detached, causing embolisms, or grow until they reduce the effectiveness of the device, giving rise to stiffening, if not quite to obstruction. Another harmful effect is the formation, on contact with the blood, of a neo-intima or pannus which may increase in thickness excessively until it compromises the functioning of the device. Other problems are due to the tendency to the formation of centres of infection which are resistant to antibiotic treatment and to interaction with the surrounding tissues, which can give rise to adhesion and/or the formation of inflammation. The object of the present invention is to provide devices for contacting a blood flow, of the type specified above, which do not give rise to the problems described. According to the present invention this object is achieved by a device as defined in the characterising portion of claim 1. A coating of this type, which may even be applied to a continuous polymeric material with a low melting point with the use of the methods described in EP-A-0 102 328 and EP-A-0 224 080, in the name of the same Applicant, confers optimal characteristics of haemocompatibility and biocompatibility on the surface of the device, considerably improving the properties of the device itself and at the same time retaining the positive characteristics deriving from the polymer used to produce the structure. Both the previous European patent applications cited above describe the possibility of depositing a layer of biocompatible carbonaceous material on a polymeric material having a certain degree of flexibility, such as that required, for example, for the stent of heart valve prosthesis. The present invention is based on the observation that, in a completely surprising and unexpected manner, a continuous film of biocompatible carbonaceous material may be deposited on an element deformable at a frequency comparable to the frequency of the heartbeat (such as a pulsating wall of the blood chamber of a pump for ventricular-assistance systems or a valve leaflet of a heart prosthesis) without resulting in the detachment or cracking of the layer of biocompatible material. This is in total contrast with the general appreciation of prior art as exemplified e.g. by DE-A-31 16 040 wherein coating of a flexible substrate was held to require necessarily a sort of a pile-of-sand structure of the coating itself. The invention will now be described purely by way of non-limiting example with reference to the appended drawings, in which: Figure 1 shows a first device for contacting a blood flow constituted by a so-called artificial ventricle produced according to the invention, Figure 2 is a section taken on the line II-II of Figure 1, and Figure 3 is a perspective view of a heart valve prosthesis also produced according to the invention. The device illustrated in Figures 1 and 2, generally indicated 1, comprises a casing of substantially-rigid or moderately-flexible plastics material, usually constituted by two shells 2 and 3 between which a flexible diaphragm 4, also made of a continuous polymeric material, such as a thin sheet of polyurethane, is interposed. The diaphragm 4 divides the space within the device 1 into two chambers indicated 5 and 6 respectively in the sectioned view of Figure 2. The chamber 5 constitutes the so-called blood chamber of the device 1 which is intended for use in generating a pulsed blood flow to replace or assist a natural ventricle or heart muscle which is diseased or undergoing a surgical operation. For this purpose a blood supply duct 7, usually connected to a heart atrium or a device which simulates its function, and a blood delivery duct 8, intended for connection to or to replace the patient's aorta, are connected to two orifices provided in the blood chamber 5. Both the ducts 7 and 8 may be constituted by artificial ducts, such as those usually referred to as "vascular grafts" or other artificial ducts such as cannulae. The ducts 7 and 8 normally have respective associated valves which may have structures similar to that of the valve 9 illustrated in Figure 3, which will be returned to below. A further pumping duct 10 opens into the second chamber 6, or pumping chamber, of the device 1, and through this it is possible to supply a pulsed hydraulic or pneumatic flow into the chamber 6 whose function is to deform the diaphragm 4 rhythmically from the position shown in a continuous line in Figure 2 (position corresponding to the maximum volume of the blood chamber 5) to the position shown schematically in broken outline in the same drawing (the position which corresponds to the maximum reduction in volume of the blood chamber 5). By means of the rhythmic deformation of the diaphragm 4 caused by the supply to the pumping chamber 6 governed by regulating action exerted alternatively by the valves associated with the ducts 7 and 8, the device 1 enables a pulsed flow of blood to be generated at the output of the duct 8, thus fulfilling a function completely analogous to that of the ventricles of a natural heart muscle. The structure of the device 1 described above must be considered entirely known. It is, however, illustrative in character, numerous other solutions having been proposed which enable a completely similar function to be achieved by the cyclic compression of the blood chamber by means of a different type. It has, in fact, been suggested, for example, to use devices which are operated electrically, electromagnetically, or even by the contraction of a suitably conditioned skeletal muscle of the patient instead of a thrusting action exerted pneumatically or hydraulically. A fundamental characteristic of all the devices in question is the presence of at least one wall in the blood pumping chamber which is exposed to the blood and is cyclically deformed at a frequency comparable to the frequency of the heartbeat. An essentially similar situation is found in valve prostheses such as the prosthesis or valve indicated 9 in Figure 3. In addition to a stent 11 of substantially rigid or moderately flexible material (and possibly a suture ring not illustrated in the drawings), the valve 9 includes one or more valve leaflets 12 which are intended to deform cyclically at a frequency similar to the frequency of the heartbeat to allow the blood to flow freely through the prosthesis 9 in one direction and to stop the flow in the opposite direction as a result of the converging movement of the valve leaflets 12 to obstruct the central orifice of the stent 11. Three valve leaflets 12 are usually provided in a configuration which reproduces essentially the configuration of physiological aortic valves. Models with one or two leaflets are also known, as is the possibility of using yet a different number. The fundamental characteristic of the devices 1 and 9 produced in accordance with the invention is the fact that at least the elements thereof which are exposed to the blood and intended to be deformed cyclically at the heartbeat frequency (in the specific case, the diaphragm 4 and the valve leaflets 12) have a layer (film) 13 of biocompatible carbonaceous material which covers them completely or covers the most critical parts thereof. In particular, as far as the diaphragm 4 is concerned, the coating is applied to the surface facing the blood chamber 5. It may, however, also be advantageous to apply the same coating to the internal wall of the casing 3 and to the surfaces of the blood ducts 7 and 8, as well as to the diaphragm 4. In this way, all the parts of the device 1 which are intended to come into contact with the blood are coated with carbonaceous material and are completely haemocompatible and biocompatible. Naturally, if the device 1 as a whole is intended to be implanted in a patient's body or, at least, if its outer surface is also to come into contact with biological masses, it may be advantageous to apply the coating 13 to the outer surface of the device as well. This is also true - a fortiori - for the valve prosthesis 9, whose stent parts and any suture ring may be coated with biocompatible carbonaceous material as well as the valve leaflets 12 (on one or both the opposite faces thereof). The best results are obtained with a film of biocompatible carbonaceous material having an intrinsically turbostratic structure with a density greater than or equal to approximately 2.1 g/cm³ and a thickness of between about 10⁻⁷ and about 10⁻⁶ metres (about 0.1 and about 1 micron). The dimensions of the carbon crystals in such a film are less than about 10⁻⁸ metres (100A) The Applicant has been able to show that such a coating film is not subject to detachment and/or cracking even if applied to highly flexible elements such as the diaphragm 4 of the device 1 and the valve leaflets 12 of the valve 9, which are intended to be deformed cyclically at a frequency comparable to the frequency of the heartbeat, that is to say, at a frequency of from about 25 to about 200 beats/minute. The film 13 may be deposited by various techniques known in the art. Particularly good results are obtained by the sputtering methods and equipment described in European patent applications Nos. 0 102 328 and 0224 080 in the name of the same Applicant already quoted above.

Claims: A device in use contacting a blood flow including at least one element (4; 12) with portions which are exposed to the blood and are deformable cyclically at a frequency comparable to the frequency of the heartbeat, whereby the cyclically-deformable element (4; 12) has a coating (13) of biocompatible carbonaceous material sputtered on at least part of the portions which are exposed to the blood and characterized in that the coating is a continuum of carbon crystals having dimensions less than 10⁻⁸ metres (100Å). A device according to Claim 1, characterised in that the coating (13) is constituted by carbonaceous material with an intrinsically turbostratic structure. A device according to any one of the preceding claims, characterised in that the coating (13) has a density of not less than about 2.1 g/cm³. A device according to any one of the preceding claims, characterised in that the coating has a thickness substantially between 10⁻⁷ and 10⁻⁶ metres (0.1 and 1 micron). A device according to any one of Claims 1 to 4, characterised in that the cyclically-deformable element (4; 12) is constituted by a continuous polymeric material. A device according to Claim 5, characterised in that the cyclically-deformable element (4, 12) is constituted by a polymeric material selected from the group consisting of polyurethanes, polytetrafluorethylene, polyesters and silicone polymers. A device according to any one of the preceding claims, characterised in that it comprises a blood chamber (5) with at least one wall portion (4) which is deformable cyclically to pump the blood, and in that the coating (13) of biocompatible carbonaceous material (13) is provided at least on part of this deformable portion of wall (4). A device according to Claim 7, characterised in that the blood chamber (5) is defined by walls (3, 4) completely covered with the coating (13) of biocompatible carbonaceous material. A device according to any one of Claims 1 to 6, in the form of a valve (9) for controlling a blood flow, including at least one cyclically-deformable valve leaflet (12), characterised in that the coating (13) of biocompatible carbonaceous material is provided on the at least one part of the valve leaflet (12). A device according to Claim 9, characterised in that the at least one valve leaflet (12) has opposite faces and in that the coating (13) of biocompatible carbonaceous material is provided on the two opposite faces. A device according to any one of the preceding claims, characterised in that the coating (13) of biocompatible carbonaceous material is provided on substantially the whole of the device.

Inventors: ARRU, PIETRO, RINALDI, STEFANO, SANTI, MARCO, VALLANA, FRANCO
Applicants: SORIN BIOMEDICA S.P.A.
Application year: 1988
Main classification: A61M1
IPC codes: A61F2, A61M1